Gleneagles Hospital Hong Kong

What Gleneagles Hospital Hong Kong does

Gleneagles Hospital Hong Kong is a 500-bed, multi-specialty private tertiary hospital operating in Wong Chuk Hang, Hong Kong. It opened in March 2017 as a joint venture between IHH Healthcare (manager of 89 hospitals across 10 countries) and CTF Services Limited, with the University of Hong Kong serving as its exclusive clinical governance partner. The hospital delivers integrated services across more than 35 specialties and subspecialties, including 24-hour outpatient and emergency care, specialist outpatient clinics, advanced surgery (robotic-assisted joint replacement, urology, and gastrointestinal procedures), oncology (including Histotripsy non-invasive liver cancer treatment — the first private offering of this modality in Asia), and maternal-fetal medicine. Its integrated network also encompasses Gleneagles Healthcare primary care clinics, Gleneagles Medical Clinic Central, Gleneagles MediCentre (Admiralty ambulatory care), the Pro-HEART Cardiac Centre, Primo Surgical Centre, and online pharmacy services (Gleneagles PharmaHome).

The hospital runs a multi-channel revenue model combining unit-priced inpatient services, all-inclusive fixed-price medical packages with publicly disclosed fee schedules, direct billing through partnerships with Bowtie, AIA Hong Kong, FWD, FTLife, and CTF Life, and recurring-style virtual consultation services. Distribution blends self-pay patients, insurance network policyholders, government Health Care Voucher Scheme participants, and corporate clients. From 2023 onward, the hospital has leaned into AI-driven differentiation, deploying clinical note-taking AI, AI-assisted imaging and endoscopy diagnostics, the MoniCare remote care service, and an AI-powered personalised longevity programme; it established the IHH Healthcare North Asia AI Lab in June 2025 and signed a strategic collaboration with the Chinese Academy of Sciences' Centre for AI and Robotics in March 2026.

Customer segments span Hong Kong individual patients, Greater Bay Area cross-border patients, corporate employee health programmes, and international medical tourism. The hospital actively pursues specialty expansion (Histotripsy, robotic surgery, precision oncology), geographic expansion via GBA Healthcare Group, Caritas-Parkway Precious Blood Hospital redevelopment, and Shanghai cross-border specialist practice, and ecosystem expansion through insurer, academic, and AI-tech partnerships.

Name

Gleneagles Hospital Hong Kong

Legal name

GHK Hospital Limited

Website

https://gleneagles.hk

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Gleneagles Hospital Hong Kong is a 500-bed, multi-specialty private tertiary hospital in Wong Chuk Hang, jointly owned by IHH Healthcare and CTF Services, that serves Hong Kong residents, Greater Bay Area cross-border patients, and corporate/insurance clients across 35+ specialties using advanced technologies such as robotic surgery and Histotripsy.

Ownership category

akta.pro rank

Product category

Private Tertiary Hospital Services

NAICS

General Medical and Surgical Hospitals (62211), General Medical and Surgical Hospitals (6221), Freestanding Ambulatory Surgical and Emergency Centers (621493), Other Ambulatory Health Care Services (6219)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Home Health Care Services (8082), Services-Health Services (8000)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA), Hospital-at-Home & Acute Virtual Care Platforms (HLALABAC), Hospital-at-Home & Virtual Ward IoT (HLACAPAC), Medication Therapy Management (MTM) & Clinical Pharmacy Services (HLAFALAH)

Keywords

• Private hospital services
• Multi-specialty tertiary care
• Robotic surgery services
• Telemedicine consultations
• Ambulatory healthcare services

Headquarters

HQ city

Hong Kong

HQ country

Hong Kong SAR China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Hospital Services: Comprehensive inpatient and outpatient medical services across more than 35 specialties. Revenue generated from room charges, surgical procedures, diagnostic services, specialist consultations, and treatment packages
2. All-inclusive Fixed Price Medical Packages: Bundled pricing for specific procedures and treatments providing transparency and predictability for patients
3. Insurance Direct Billing: Direct settlement with insurance companies including partnerships with Bowtie, AIA, FWD, FTLife, and other providers
4. Virtual Consultation Services: Telemedicine and virtual consultation services for patients requiring remote care

Pricing tiers

Go-to-market motion1 record

Distribution channels8 records

Marketing channels6 records

Core offering

Gleneagles Hospital Hong Kong is a 500-bed multi-specialty private tertiary hospital providing inpatient care, 24-hour outpatient and emergency services, specialist consultations, surgery, and diagnostics across more than 35 specialties. Its offering spans an integrated network including primary care clinics, an ambulatory care centre, specialist surgical and cardiac centres, an online pharmacy, a patient mobile app, and a telemedicine/virtual consultation platform. The hospital distinguishes itself with advanced treatments such as Histotripsy for liver cancer, robotic-arm assisted surgery, AI-assisted diagnostics, and AI-powered personalised longevity and remote care programmes.

Product overview

Gleneagles Hospital Hong Kong is a multi-specialty private tertiary hospital offering a comprehensive integrated healthcare network. The hospital provides 500 beds across more than 35 specialties and subspecialties, combining advanced medical technology with personalized patient care. The product portfolio includes core hospital services (24-hour emergency, inpatient care, surgery), specialized centres of excellence (cancer services with Histotripsy, cardiac, maternal-fetal medicine, joint replacement with robotic surgery), and digital health products (My Gleneagles SmartHealth app, Virtual Consultation telemedicine platform, Gleneagles MediCentre ambulatory centre). The hospital has recently expanded into AI-powered healthcare solutions including personalised longevity programmes, AI-assisted diagnostics, and remote patient monitoring services, positioning itself as a technology-forward healthcare provider in Hong Kong.

Differentiator

Problem solved

Functional benefit

Brands

• Gleneagles Healthcare: Primary care clinics network providing general and specialist outpatient services
• Gleneagles Medical Clinic Central
• Gleneagles MediCentre
• Gleneagles Primo Surgical Centre
• Gleneagles Pro-HEART Cardiac Centre
• My Gleneagles SmartHealth
• Gleneagles Dispensary
• Gleneagles PharmaHome

Products and services

• 24-hour Outpatient and Emergency Services
• Inpatient Services
• All-inclusive Medical Packages

Quantifiable outcome

• First private hospital in Asia to offer Histotripsy liver cancer treatment
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability13 records

Feature6 records

Partnerships

23 partnerships are on record, tiered core and minor.

• Chinese Academy of Sciences' Centre for Artificial Intelligence and Robotics (CAIR)coreStrategic or Co-development Partner · 25 March 2026Strategic partnership making Gleneagles the first local private healthcare strategic partner of CAIR. Collaboration focuses on six areas: AI-driven patient workflow optimization, medical consultation chatbots, AI-assisted diagnostic support for medical imaging, liver fibrosis screening, and medical simulation for education. Both parties will jointly define technical requirements and clinical validation plans.
• Quantum LifecoreStrategic or Co-development Partner · 12 December 2025Collaboration to launch Hong Kong's first AI-powered personalised longevity programme. The programme promotes preventive medicine through AI-driven health assessments and personalized recommendations.
• CTF LifecoreGTM or Marketing Partner · 28 October 2025Strategic partnership expanding CTF Life's hospital network in Hong Kong. Gleneagles serves as designated medical network partner providing territory-wide coverage and exclusive health management programs for CTF Life customers.
• CUHK Medical CentreminorOthers · 28 October 2025Medical network partnership as part of CTF Life's expanded hospital network for territory-wide coverage.
• Hong Kong Baptist HospitalminorOthers · 28 October 2025Medical network partnership as part of CTF Life's expanded hospital network for territory-wide coverage.
• Emerging Viral DiagnosticscoreStrategic or Co-development Partner · 26 May 2025Partnership to advance medical innovation and diagnostic excellence. Collaboration aims to co-create innovative community healthcare ecosystem.
• PanopticAI (HKUST Startup)coreTechnology or Integration · 26 May 2025Partnership to pioneer AI-driven patient care solutions. PanopticAI provides AI-powered health monitoring and assessment technology.
• SmartCare (HKUST Startup)coreTechnology or Integration · 26 May 2025Partnership to pioneer AI-driven patient care solutions. SmartCare provides healthtech solutions for enhanced patient care.
• HKUMed (The University of Hong Kong)coreStrategic or Co-development Partner · 19 September 2024Partnership to launch Clinical Trials Centre to advance medical research and healthcare outcomes. Collaboration for clinical research and development.
• GBA Healthcare GroupcoreStrategic or Co-development Partner · 24 May 2024Collaborative agreement to build value-based care model in Greater Bay Area. Focus on integrated healthcare delivery across the region.
• Caritas Hong Kong / Precious Blood HospitalcoreStrategic or Co-development Partner · 23 May 2024Collaboration through Parkway Medical Services to redevelop Precious Blood Hospital (Caritas) to provide excellent and comprehensive healthcare services.
• SilveridersminorGTM or Marketing Partner · 2 February 2024Health education campaign to promote early detection of mild cognitive impairment and Alzheimer's disease.
• Immuno Cure and HKUminorStrategic or Co-development Partner · 21 June 2023Clinical trial collaboration for COVID-19 booster vaccine. Phase IIA clinical trial conducted at Gleneagles.
• Hong Kong Science and Technology Parks (HKSTP)coreStrategic or Co-development Partner · 12 June 2023Collaboration to drive cutting-edge innovation and advance patient care. Partnership leverages HKSTP's innovation ecosystem.
• Precision Robotics (Hong Kong) LimitedcoreTechnology or Integration · 1 February 2023Partnership to enhance surgical robotic innovations. Collaboration for developing and deploying surgical robotics technology.
• Hospital AuthoritycoreStrategic or Co-development Partner · 26 August 2022Collaboration to provide free teleconsultation service with medication to support COVID-19 elderly in community during pandemic.
• HKU-CTC and SINOVACminorStrategic or Co-development Partner · 4 July 2022Clinical trial of Omicron-specific inactivated vaccine for booster use in Hong Kong. Joint research collaboration.
• FTLifecoreGTM or Marketing Partner · 4 May 2021'Insurance + Medical Care' strategic partnership creating synergy in New World Group's ecosystem. Exclusive health management programs.
• HKT and FWDcoreStrategic or Co-development Partner · 13 April 2021Co-launch of innovative hybrid hypertension care programme combining telemedicine and insurance services.
• BowtiecoreGTM or Marketing Partner · 8 April 2021Launch of first-ever 'Medical Insurance + Wellness' Package. VHIS rider plan offering full reimbursement and annual health check. Multiple subsequent collaborations including Histotripsy treatment inclusion.
• AIA Hong Kong and HKTcoreStrategic or Co-development Partner · 2 December 2020Cross-industry collaboration launching Hong Kong's first hospital-supported telemedicine service in the insurance industry.
• IHH HealthcarecoreStrategic or Co-development PartnerParent company and joint venture partner. IHH Healthcare is one of the world's largest private healthcare services providers operating 89 hospitals in 10 countries. Gleneagles is managed by IHH Healthcare.
• The University of Hong Kong (HKU)coreStrategic or Co-development PartnerExclusive clinical partner responsible for clinical governance. Partnership ensures access to top medical talent, clinical governance excellence, and enables exposure to complex cases for staff development.

Scale indicators8 records

Recent moves15 records

Expansion highlights6 records

Direct peers

• Matilda International Hospital: Boutique private hospital on Hong Kong Island with a similar premium positioning and international patient focus. Competes for affluent local and expatriate patients.
• Hong Kong Adventist Hospital: Multi-site private hospital group (Stubbs Road and Tsuen Wan) with comparable tertiary capabilities. Overlaps with Gleneagles on surgical, oncology and maternity services and direct-billing models.
• Precious Blood Hospital (Caritas): Hong Kong private hospital being redeveloped in collaboration with Parkway Medical Services (Gleneagles' affiliated operator). Provides a direct in-market peer reference and an upcoming competitive footprint on Hong Kong Island.
• Union Hospital: Private hospital in Tai Wai offering a similar multi-specialty service mix. Competes with Gleneagles for New Territories and Kowloon private patients across general and specialty services.
• Hong Kong Sanatorium & Hospital: One of Hong Kong's largest and most established private multi-specialty hospitals, offering similar tertiary services across a broad specialty mix. Directly competes for private-paying patients and complex-case referrals in Hong Kong.
• Hong Kong Baptist Hospital: Long-standing private multi-specialty hospital in Kowloon serving a comparable patient demographic. Overlaps with Gleneagles across general specialties and is part of the same CTF Life network partnership.
• CUHK Medical Centre: Newer non-profit private teaching hospital affiliated with the Chinese University of Hong Kong. Competes for premium private patients and complex cases, with strong academic governance analogous to Gleneagles' HKU partnership.
• St. Paul's Hospital: Established private hospital in Causeway Bay offering multi-specialty inpatient and outpatient services. Directly competes for Hong Kong Island private patients and corporate/insurance contracts.

Regional players

• Raffles Medical Group: Integrated private healthcare provider with hospital and clinic operations across Asia (Singapore, Hong Kong, China). Comparable as a regional multi-market private hospital/group operator, though Hong Kong presence is smaller.

Broad incumbents

• IHH Healthcare: Parent group and one of the world's largest private healthcare operators (89 hospitals in 10 countries). Comparable as the broader corporate platform of which Gleneagles HK is a flagship North Asia asset.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC5oW6_eTrf-qBWC0nYokr_A
• Facebookfacebook.com/GHK.Hospital
• LinkedInlinkedin.com/company/gleneagleshospitalhongkong

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gleneagles Hospital Hong Kong